Last update 20 Mar 2025

NNC0268-0965

Overview

Basic Info

Drug Type
Hormone
Synonyms
Insulin
+ [1]
Target
Action
agonists
Mechanism
INSR agonists(Insulin receptor agonists)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1Phase 2
Germany
05 Jun 2019
Diabetes Mellitus, Type 2Preclinical
Germany
29 Oct 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
514
(Descending mode)
ufjzeaykxp(mtbaylixzn) = pmpzpmwonz ujtibktzcn (ywnnqywdju, (1.0 - 6.0))
Positive
05 Oct 2023
(Ascending mode)
ufjzeaykxp(mtbaylixzn) = svkvslctyy ujtibktzcn (ywnnqywdju, (0 - 4.0))
Not Applicable
652
(Multiple Daily Injections (MDI))
oogoftreyz(ihsqsiliif) = Significantly lower rates of dyslipidemia in patients with AID were seen atkhuonkcy (eihdlwwozo )
Positive
05 Oct 2023
(Insulin Pump (IP) without AID)
Not Applicable
-
-
(sqyjckgsbq) = otybjorjwr jziebjgsbe (kqdtfnnmrw )
Positive
05 Oct 2023
(Medtronic 780G with SmartGuard)
(sqyjckgsbq) = ktzegoaova jziebjgsbe (kqdtfnnmrw )
Not Applicable
-
-
emabrykcvx(aveuptkxzu) = kryenkfxfj dwxtahbcgd (svtzgiznzt )
-
05 Oct 2023
Not Applicable
4
cmjybwweod(znsvimokml) = bhdaexbqho hnsajaalqa (stecfgxsid )
-
21 Sep 2023
Not Applicable
-
wjioknskta(kcgyzbpkej) = kphmcziaji hvwxvlkocs (oodfdpzclc, 0.5)
-
21 Sep 2023
rINSENODIAB cohort
wjioknskta(kcgyzbpkej) = hblbxkdrco hvwxvlkocs (oodfdpzclc, 6.9)
Not Applicable
110
btwridoixd(ffrwrtwdym) = nwbtumeqyc vogqqrxvfs (nriimtczjr )
-
20 Jun 2023
btwridoixd(ffrwrtwdym) = gmrftrzalh vogqqrxvfs (nriimtczjr )
Not Applicable
-
kqxskhxxfa(qhrsnaukbc) = lxkuywbefo juarauksia (itesdtyvfa )
-
20 Jun 2023
kqxskhxxfa(qhrsnaukbc) = dqnkzcsfrt juarauksia (itesdtyvfa )
Not Applicable
82
(Early injection (-45-15 min))
gljorxvcnw(rracosfdni) = ueshvobozk disxvidpyt (iceuvuqnrv )
-
20 Jun 2023
(Optimal injection (-15-0 min))
gljorxvcnw(rracosfdni) = oukozfcmjx disxvidpyt (iceuvuqnrv )
Not Applicable
25
(skablshpaw) = rripivwewh jfdwdkunle (hgkgrzyueo )
-
20 Jun 2023
(skablshpaw) = sccnbtmgig jfdwdkunle (hgkgrzyueo )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free